Heterologous protection against influenza by injection of DNA encoding a viral protein

Science. 1993 Mar 19;259(5102):1745-9. doi: 10.1126/science.8456302.

Abstract

Cytotoxic T lymphocytes (CTLs) specific for conserved viral antigens can respond to different strains of virus, in contrast to antibodies, which are generally strain-specific. The generation of such CTLs in vivo usually requires endogenous expression of the antigen, as occurs in the case of virus infection. To generate a viral antigen for presentation to the immune system without the limitations of direct peptide delivery or viral vectors, plasmid DNA encoding influenza A nucleoprotein was injected into the quadriceps of BALB/c mice. This resulted in the generation of nucleoprotein-specific CTLs and protection from a subsequent challenge with a heterologous strain of influenza A virus, as measured by decreased viral lung titers, inhibition of mass loss, and increased survival.

MeSH terms

  • Animals
  • Base Sequence
  • DNA, Viral / genetics*
  • DNA, Viral / therapeutic use
  • Gene Expression
  • Genetic Vectors
  • Histocompatibility Antigens Class I / immunology
  • Immunization
  • Influenza A virus / genetics*
  • Influenza A virus / immunology
  • Influenza A virus / isolation & purification
  • Lung / microbiology
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • Muscles / metabolism
  • Nucleocapsid Proteins
  • Nucleoproteins / genetics*
  • Nucleoproteins / immunology*
  • Orthomyxoviridae Infections / microbiology
  • Orthomyxoviridae Infections / prevention & control*
  • Plasmids
  • RNA-Binding Proteins*
  • T-Lymphocytes, Cytotoxic / immunology
  • Transfection
  • Viral Core Proteins / genetics*
  • Viral Core Proteins / immunology*
  • Viral Vaccines / genetics*

Substances

  • DNA, Viral
  • Histocompatibility Antigens Class I
  • NP protein, Influenza A virus
  • Nucleocapsid Proteins
  • Nucleoproteins
  • RNA-Binding Proteins
  • Viral Core Proteins
  • Viral Vaccines